Detailed information for compound 736064

Basic information

Technical information
  • TDR Targets ID: 736064
  • Name: 5-chloro-3-hydroxy-1-[(4-methylphenyl)methyl] -3-(2-oxo-2-pyridin-3-ylethyl)indol-2-one
  • MW: 406.862 | Formula: C23H19ClN2O3
  • H donors: 1 H acceptors: 4 LogP: 3.51 Rotable bonds: 5
    Rule of 5 violations (Lipinski): 1
  • SMILES: Clc1ccc2c(c1)C(O)(CC(=O)c1cccnc1)C(=O)N2Cc1ccc(cc1)C
  • InChi: 1S/C23H19ClN2O3/c1-15-4-6-16(7-5-15)14-26-20-9-8-18(24)11-19(20)23(29,22(26)28)12-21(27)17-3-2-10-25-13-17/h2-11,13,29H,12,14H2,1H3
  • InChiKey: KZKGMZYTGZISOC-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 5-chloro-3-hydroxy-1-[(4-methylphenyl)methyl]-3-[2-oxo-2-(3-pyridyl)ethyl]indolin-2-one
  • 5-chloro-3-hydroxy-1-[(4-methylphenyl)methyl]-3-[2-oxo-2-(3-pyridyl)ethyl]-2-indolinone
  • 5-chloro-3-hydroxy-3-[2-keto-2-(3-pyridyl)ethyl]-1-(4-methylbenzyl)oxindole
  • 5-chloro-3-hydroxy-1-[(4-methylphenyl)methyl]-3-(2-oxo-2-pyridin-3-yl-ethyl)indol-2-one
  • STK214903
  • CBKinase1_017461
  • CBKinase1_005061

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Echinococcus multilocularis small conductance calcium activated potassium 0.0632 0.7187 0.7147
Giardia lamblia Kinase, PLK 0.0093 0.0562 0.5
Echinococcus granulosus serine:threonine protein kinase PLK1 0.0093 0.0562 0.0426
Entamoeba histolytica serine/threonine protein kinase, putative 0.0093 0.0562 0.5
Trichomonas vaginalis CAMK family protein kinase 0.0093 0.0562 0.5
Loa Loa (eye worm) hypothetical protein 0.0121 0.0904 0.0773
Schistosoma mansoni serine/threonine protein kinase 0.0093 0.0562 0.0718
Trichomonas vaginalis CAMK family protein kinase 0.0093 0.0562 0.5
Trichomonas vaginalis CAMK family protein kinase 0.0093 0.0562 0.5
Echinococcus multilocularis L aminoadipate semialdehyde 0.0082 0.0425 0.0287
Schistosoma mansoni hypothetical protein 0.0632 0.7187 0.9179
Loa Loa (eye worm) hypothetical protein 0.0176 0.1589 0.1468
Brugia malayi hypothetical protein 0.0176 0.1589 0.1468
Brugia malayi Kelch motif family protein 0.0176 0.1589 0.1468
Schistosoma mansoni ero1-related 0.0059 0.0142 0.0181
Mycobacterium tuberculosis Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras 0.0094 0.058 1
Brugia malayi aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase 0.0082 0.0425 0.0287
Loa Loa (eye worm) hypothetical protein 0.0082 0.0425 0.0287
Trichomonas vaginalis CAMK family protein kinase 0.0093 0.0562 0.5
Echinococcus granulosus small conductance calcium activated potassium 0.0632 0.7187 0.7147
Echinococcus multilocularis serine:threonine protein kinase PLK1 0.0093 0.0562 0.0426
Loa Loa (eye worm) hypothetical protein 0.0205 0.1936 0.182
Trichomonas vaginalis CAMK family protein kinase 0.0093 0.0562 0.5
Loa Loa (eye worm) PLK/PLK1 protein kinase 0.0093 0.0562 0.0426
Trypanosoma cruzi polo-like protein kinase, putative 0.0093 0.0562 1
Toxoplasma gondii endoplasmic reticulum oxidoreductin, putative 0.0059 0.0142 0.5
Mycobacterium leprae DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE 0.0094 0.058 1
Brugia malayi serine/threonine-protein kinase plk-2 0.0093 0.0562 0.0426
Echinococcus granulosus microtubule associated protein 2 0.0679 0.7769 0.7737
Trichomonas vaginalis CAMK family protein kinase 0.0093 0.0562 0.5
Onchocerca volvulus Serine\/threonine kinase homolog 0.0093 0.0562 1
Loa Loa (eye worm) hypothetical protein 0.0279 0.2852 0.2749
Schistosoma mansoni calcium-activated potassium channel 0.0484 0.5369 0.6857
Leishmania major protein kinase, putative,polo-like protein kinase, putative 0.0093 0.0562 1
Echinococcus granulosus integrin beta 2 0.086 1 1
Plasmodium falciparum endoplasmic reticulum oxidoreductin, putative 0.0059 0.0142 0.5
Mycobacterium tuberculosis Probable oxidoreductase 0.0094 0.058 1
Trichomonas vaginalis CAMK family protein kinase 0.0093 0.0562 0.5
Loa Loa (eye worm) integrin beta-2 0.086 1 1
Schistosoma mansoni aminoadipate-semialdehyde dehydrogenase 0.0082 0.0425 0.0543
Trypanosoma cruzi polo-like protein kinase, putative 0.0093 0.0562 1
Loa Loa (eye worm) hypothetical protein 0.0632 0.7187 0.7147
Schistosoma mansoni calcium-activated potassium channel 0.0632 0.7187 0.9179
Echinococcus multilocularis integrin beta 2 0.086 1 1
Echinococcus multilocularis microtubule associated protein 2 0.0679 0.7769 0.7737
Mycobacterium tuberculosis NAD(P)H quinone reductase LpdA 0.0094 0.058 1
Plasmodium vivax endoplasmic reticulum oxidoreductin, putative 0.0059 0.0142 0.5
Echinococcus granulosus L aminoadipate semialdehyde 0.0082 0.0425 0.0287
Schistosoma mansoni integrin beta subunit 0.0684 0.783 1
Trypanosoma brucei polo-like protein kinase 0.0093 0.0562 1
Loa Loa (eye worm) kelch domain-containing protein family protein 0.0176 0.1589 0.1468
Schistosoma mansoni microtubule-associated protein tau 0.0679 0.7769 0.9923

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.